Randomized Trial of Interventions for Smoking Cessation among Medicaid Beneficiaries with Mental Illness

Psychiatric Services

Volumn 69, Issue 3, 2018, Pages 274-280

  Brunette, Mary F ^a,c,e   Pratt, Sarah I ^a,c   Bartels, Stephen J ^a,c   Scherer, Emily A ^b   Sigmon, Stacey C ^d   Ferron, Joelle C ^d   Santos, Meghan ^d   Williams, Gail E ^d   Kosydar, Samuel ^d   Wolfe, Rosemarie S ^d   Lotz, Doris ^e   Capuchino, Kelley ^e  

^a Society for Research on Nicotine and Tobacco   (Italy)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^e NEW HAMPSHIRE DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CARBON MONOXIDE; PSYCHOTROPIC AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; BREATHING; CIGARETTE; CLINICAL OUTCOME; COGNITIVE BEHAVIORAL THERAPY; COMMUNITY MENTAL HEALTH CENTER; CONTROLLED STUDY; DIAGNOSIS RELATED GROUP; DISEASE SEVERITY; DSM-IV-TR; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; LOWEST INCOME GROUP; LUNG CANCER; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAID; MENTAL DISEASE; MENTAL HEALTH CARE; MIDDLE AGED; NICOTINE REPLACEMENT THERAPY; PNEUMONIA; POST HOC ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SCHIZOPHRENIA SPECTRUM DISORDER; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; TOBACCO USE; TREATMENT OUTCOME; WITHDRAWAL SYNDROME; DRUG THERAPY; MENTAL HEALTH SERVICE; MULTIMODALITY CANCER THERAPY; POVERTY; PROCEDURES; REWARD; THERAPY; UNITED STATES;

ADULT; COGNITIVE BEHAVIORAL THERAPY; COMBINED MODALITY THERAPY; COMMUNITY MENTAL HEALTH SERVICES; FEMALE; HUMANS; MALE; MEDICAID; MENTAL DISORDERS; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); POVERTY; REWARD; SMOKING; SMOKING CESSATION; UNITED STATES;

EID: 85042759384     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.201700245     Document Type: Article

References (43)

1. Smith PH, Mazure CM, McKee SA: Smoking and mental illness in the US population. Tobacco Control 23(e2):e147-e153, 2014
2. Evins AE, Cather C, Deckersbach T, et al: A double-blind placebocontrolled trial of bupropion sustained-release for smoking cessation in schizophrenia. Journal of Clinical Psychopharmacology 25:218-225, 2005
3. George TP, Vessicchio JC, Termine A, et al: A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biological Psychiatry 52:53-61, 2002
4. Tidey JW, Miller ME: Smoking cessation and reduction in people with chronic mental illness. BMJ 351:h4065, 2015
5. Roberts E, Eden Evins A, McNeill A, et al: Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: A systematic review and network meta-Analysis. Addiction 111:599-612, 2016
6. Stead LF, Hartmann-Boyce J, Perera R, et al: Telephone counselling for smoking cessation. Cochrane Database of Systematic Reviews 8:CD002850, 2013
7. Tedeschi GJ, Cummins SE, Anderson CM, et al: Smokers with selfreported mental health conditions: A case for screening in the context of tobacco cessation services. PLoS One 11:e0159127, 2016
8. Lichtenstein E, Zhu SH, Tedeschi GJ: Smoking cessation quitlines: An underrecognized intervention success story. American Psychologist 65:252-261, 2010
9. Morris CD, Waxmonsky JA, May MG, et al: Smoking reduction for persons with mental illnesses: 6-month results from communitybased interventions. Community Mental Health Journal 47:694-702, 2011
10. Higgins ST, Silverman K, Heil SH: Contingency Management in Substance Abuse Treatment New York. NY, Guilford, 2008
11. Higgins ST, Petry NM: Contingency management: incentives for sobriety. Alcohol Research and Health 23:122-127, 1999
12. Hursh SR: Economic concepts for the analysis of behavior. Journal of the Experimental Analysis of Behavior 34:219-238, 1980
13. Sigmon SC, Patrick ME: The use of financial incentives in promoting smoking cessation. Preventive Medicine 55(suppl):S24-S32, 2012
14. Sigmon SC, Miller ME, Meyer AC, et al: Financial incentives to promote extended smoking abstinence in opioid-maintained patients: A randomized trial. Addiction 111:903-912, 2016
15. Volpp KG, Gurmankin Levy A, Asch DA, et al: A randomized controlled trial of financial incentives for smoking cessation. Cancer Epidemiology, Biomarkers and Prevention 15:12-18, 2006
16. Etter JF, Schmid F: Effects of Large Financial Incentives for Long-Term Smoking Cessation: A Randomized Trial. Journal of the American College of Cardiology 68:777-785, 2016
17. Kendzor DE, Businelle MS, Poonawalla IB, et al: Financial incentives for abstinence among socioeconomically disadvantaged individuals in smoking cessation treatment. American Journal of Public Health 105:1198-1205, 2015
18. Volpp KG, Troxel AB, Pauly MV, et al: A randomized, controlled trial of financial incentives for smoking cessation. New England Journal of Medicine 360:699-709, 2009
19. Brunette MF, Dzebisashvili N, Xie H, et al: Expanding cessation pharmacotherapy via videoconference educational outreach to prescribers. Nicotine and Tobacco Research 17:960-967, 2015
20. Siu AL, US Preventive Services Task Force: Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: US Preventive Services Task Force recommendation statement. Annals of Internal Medicine 163:622-634, 2015
21. Lavori PW, Rush AJ, Wisniewski SR, et al: Strengthening clinical effectiveness trials: equipoise-stratified randomization. Biological Psychiatry 50:792-801, 2001
22. Lai TL, Lavori PW: Innovative clinical trial designs: Toward a 21stcentury health care system. Statistics in Biosciences 3:145-168, 2011
23. March J, Kraemer HC, Trivedi M, et al: What have we learned about trial design from NIMH-funded pragmatic trials? Neuropsychopharmacology 35:2491-2501, 2010
24. Brunette MF, Ferron JC, McHugo GJ, et al: An electronic decision support system to motivate people with severe mental illnesses to quit smoking. Psychiatric Services 62:360-366, 2011
25. Brunette MF, Ferron JC, Drake RE, et al: Carbon monoxide feedback in a motivational decision support system for nicotine dependence among smokers with severe mental illnesses. Journal of Substance Abuse Treatment 45:319-324, 2013
26. Join Freedom From Smoking. Chicago, American Lung Association, http://www.lung.org/stop-smoking/how-To-quit/freedom-fromsmoking. Accessed July 1, 2017
27. Addington J, el-Guebaly N, Campbell W, et al: Smoking cessation treatment for patients with schizophrenia. American Journal of Psychiatry 155:974-976, 1998
28. Jarvis MJ, Russell MA, Saloojee Y: Expired air carbon monoxide: A simple breath test of tobacco smoke intake. British Medical Journal 281:484-485, 1980
29. Benowitz NL, Ahijevych K, Jarvis MJ, et al: Biochemical verification of tobacco use and cessation. Nicotine and Tobacco Research 4:149-159, 2002
30. Brown RA, Burgess ES, Sales SD, et al: Reliability and validity of smoking timeline follow-back interview. Psychology of Addictive Behaviors 12:101-112, 1998
31. Fagerström KO: Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addictive Behaviors 3:235-241, 1978
32. Weinberger AH, Reutenauer EL, Allen TM, et al: Reliability of the Fagerström Test for Nicotine Dependence, Minnesota Nicotine Withdrawal Scale, and Tiffany Questionnaire for Smoking Urges in smokers with and without schizophrenia. Drug and Alcohol Dependence 86:278-282, 2007
33. Shern DL, Wilson NZ, Coen AS, et al: Client outcomes II: longitudinal client data from the Colorado treatment outcome study. Milbank Quarterly 72:123-148, 1994
34. Katz JN, Chang LC, Sangha O, et al: Can comorbidity be measured by questionnaire rather than medical record review? Medical Care 34:73-84, 1996
35. Metse AP, Wiggers J, Wye P, et al: Efficacy of a universal smoking cessation intervention initiated in inpatient psychiatry and continued post-discharge: A randomised controlled trial. Australian and New Zealand Journal of Psychiatry 51:366-381, 2017
36. Stockings EA, Bowman JA, Baker AL, et al: Impact of a postdischarge smoking cessation intervention for smokers admitted to an inpatient psychiatric facility: A randomized controlled trial. Nicotine and Tobacco Research 16:1417-1428, 2014
37. Evins AE, Cather C, Pratt SA, et al: Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: A randomized clinical trial. JAMA 311: 145-154, 2014
38. McFall M, Saxon AJ, Malte CA, et al: Integrating tobacco cessation into mental health care for posttraumatic stress disorder: A randomized controlled trial. JAMA 304:2485-2493, 2010
39. Williams JM, Anthenelli RM, Morris CD, et al: A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. Journal of Clinical Psychiatry 73:654-660, 2012
40. Baker A, Richmond R, Haile M, et al: A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. American Journal of Psychiatry 163:1934-1942, 2006
41. Heffner JL, Anthenelli RM, DelBello MP, et al: Mood management and nicotine patch for smoking cessation in adults with bipolar disorder. Nicotine and Tobacco Research 15:1805-1806, 2013
42. Hall SM, Tsoh JY, Prochaska JJ, et al: Treatment for cigarette smoking among depressed mental health outpatients: A randomized clinical trial. American Journal of Public Health 96:1808-1814, 2006
43. Prochaska JJ, Hall SE, Delucchi K, et al: Efficacy of initiating tobacco dependence treatment in inpatient psychiatry: A randomized controlled trial. American Journal of Public Health 104: 1557-1565, 2014